Wörmann B - Search Results

1

Proliferation of human leukemic pre-B cells induced by human bone marrow stromal cells and murine fibroblasts.

Buske C, Hiddemann W, Wörmann B. Buske C, et al. Among authors: wormann b. Cell Biol Int. 1994 Nov;18(11):1049-58. doi: 10.1006/cbir.1994.1028. Cell Biol Int. 1994. PMID: 7894389

2

Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins.

Behre G, Schedel I, Nentwig B, Wörmann B, Essink M, Hiddemann W. Behre G, et al. Among authors: wormann b. Antimicrob Agents Chemother. 1992 Oct;36(10):2139-46. doi: 10.1128/AAC.36.10.2139. Antimicrob Agents Chemother. 1992. PMID: 1444293 Free PMC article.

3

Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cells.

Hiddemann W, Schleyer E, Unterhalt M, Zühlsdorf M, Rolf C, Reuter C, Kewer U, Uhrmeister C, Wörmann B, Büchner T. Hiddemann W, et al. Among authors: wormann b. Leukemia. 1992 Dec;6(12):1273-80. Leukemia. 1992. PMID: 1453772

4

GM-CSF in the treatment of acute myeloid leukemia.

Hiddemann W, Maschmeyer G, Ludwig WD, Königsmann M, Zühlsdorf M, Wörmann B, Boeckmann A, Agion-Freire E, Innig G, Reuter C, et al. Hiddemann W, et al. Among authors: wormann b. Pathol Biol (Paris). 1992 Nov;39(9):959. Pathol Biol (Paris). 1992. PMID: 1538952 No abstract available.

5

Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis.

Terstappen LW, Safford M, Könemann S, Loken MR, Zurlutter K, Büchner T, Hiddemann W, Wörmann B. Terstappen LW, et al. Among authors: wormann b. Leukemia. 1992 Jan;6(1):70-80. Leukemia. 1992. PMID: 1540262

6

Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.

Hiddemann W, Kiehl M, Zühlsdorf M, Busemann C, Schleyer E, Wörmann B, Büchner T. Hiddemann W, et al. Among authors: wormann b. Semin Oncol. 1992 Apr;19(2 Suppl 4):31-7. Semin Oncol. 1992. PMID: 1553573

7

Longterm effects of prolonged maintenance and of very early intensification chemotherapy in AML: data from AMLCG.

Büchner T, Hiddemann W, Wörmann B, Löffler H, Maschmeyer G, Hossfeld D, Ludwig WD, Nowrousian M, Aul C, Schaefer UW, et al. Büchner T, et al. Among authors: wormann b. Leukemia. 1992;6 Suppl 2:68-71. Leukemia. 1992. PMID: 1578946 Clinical Trial.

8

Analysis of the cellular DNA and RNA content in acute leukemias by flow cytometry.

Hiddemann W, Wörmann B, Messerer D, Springefeld R, Büchner T. Hiddemann W, et al. Among authors: wormann b. J Cancer Res Clin Oncol. 1990;116(5):507-12. doi: 10.1007/BF01613003. J Cancer Res Clin Oncol. 1990. PMID: 1699947

9

Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.

Hiddemann W, Rottmann R, Wörmann B, Thiel A, Essink M, Ottensmeier C, Freund M, Büchner T, van de Loo J. Hiddemann W, et al. Among authors: wormann b. Ann Hematol. 1991 Jul;63(1):1-4. doi: 10.1007/BF01714952. Ann Hematol. 1991. PMID: 1715191

10

In vitro and in vivo effects of rh GM-CSF in acute myeloid leukemia (AML).

Wörmann B, Hiddemann W, Frisch J, Zühlsdorf M, Rottmann R, Boeckmann A, Reuter C, Freire EA, Innig G, Schulz G, et al. Wörmann B, et al. Behring Inst Mitt. 1991 Dec;(90):28-38. Behring Inst Mitt. 1991. PMID: 1801688 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters